NovaBridge Biosciences (FRA:0VY) Net Interest Margin (Bank Only) %


FRA:0VY NovaBridge Biosciences FRA:0VY
42 GF Score
Price €1.61
GF Value €38.15
Valuation Possible Value Trap
! 2 Warning Signs
View Full Analysis

What is NovaBridge Biosciences Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

FRA:0VY
42GF Score
NovaBridge Biosciences FRA:0VY
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is NovaBridge Biosciences (FRA:0VY) Overvalued in 2026?

Based on GuruFocus' analysis, NovaBridge Biosciences stock appears to be undervalued. The current stock price of €1.61 is trading 95.8% below its estimated GF Value™ of €38.15. GuruFocus considers NovaBridge Biosciences to be Possible Value Trap.

Key valuation signals for FRA:0VY:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: €38.15 vs. price of €1.61 (95.8% below fair value)
  • GF Score™: 42/100 with 2 warning signs

No single metric tells the full story. See the FRA:0VY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

NovaBridge Biosciences Business Description

Other Exchanges NBP:USA
Address 2440 Research Boulevard, Suite 400, Rockville, MD, USA, 20850
NovaBridge Biosciences operates as a biotechnology platform, combining business development and clinical research to identify and advance pharmaceutical assets. Its inventive immuno-oncology pipeline consists of three clinical stage programs, givastomig; uliledlimab; and ragistomig. Its core product, givastomig, is a potential in-class CLDN18.2 bispecific antibody for the treatment of gastric cancer and other CLDN18.2-positive gastrointestinal malignancies.
42GF Score

Get the complete analysis for FRA:0VY

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.61
Price
€38.15
GF Value